Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-09

Clinical Trial Update: The Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of Fang yi Qing Feng Shi Granules in subjects with rheumatoid arthritis; the study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fang yi Qing Feng Shi Granules

Snippet

Sponsor: Maoxiang Group Jilin Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED